This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Rajnish Kaushik in Gene Therapy
Introduction
Rajnish Kaushik is an accomplished inventor based in Grafton, MA (US). He has made significant contributions to the field of gene therapy, particularly through his innovative approaches to transducing non-dividing myeloid cells. His work has implications for enhancing the effectiveness of viral vectors in gene therapy applications.
Latest Patents
Rajnish Kaushik holds a patent titled "Method of transducing non-dividing myeloid cells utilizing chimeric murine leukemia viruses containing Vpx." This invention is directed to a chimeric gammaretrovirus that comprises a gammaretroviral virion containing a lentiviral Vpx protein. The patent outlines methods for using this chimeric gammaretrovirus to produce a murine leukemia virus (MLV) capable of transducing non-dividing cells, including quiescent (G0) cells. This advancement enhances the ability of MLVs and human immunodeficiency virus 1 (HIV-1) to transduce these challenging cell types.
Career Highlights
Rajnish Kaushik is affiliated with the University of Massachusetts, where he continues to push the boundaries of research in gene therapy. His work is characterized by a commitment to developing innovative solutions that address complex challenges in the field of molecular biology.
Collaborations
Rajnish has collaborated with notable researchers such as Mario Stevenson and Xiaonan Zhu. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in gene therapy.
Conclusion
Rajnish Kaushik's contributions to the field of gene therapy through his innovative patent and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in the treatment of diseases that involve non-dividing cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
